S&P 500 · Health Care · USD · FY end 2025-12-31
Biogen (BIIB) financials — revenue, earnings, margins, balance sheet, cash flow and dividends. 10-year history sourced from SEC filings.
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| FY2025 | 9.89B | 1.29B | 8.79 | 2.05B |
| FY2024 | 9.68B | 1.63B | 11.18 | 2.72B |
| FY2023 | 9.84B | 1.16B | 7.97 | 1.27B |
| FY2022 | 10.17B | 3.05B | 20.87 | 1.14B |
| FY2021 | 10.98B | 1.56B | 10.40 | 3.38B |